Company: ELV
Filing Date: 2025-10-21
Form Type: 10-Q
Source: 0001156039-25-000136
Chunk: 43

Company: Elevance Health, Inc.
Filing Date: 2025-10-21
Form: 10-Q
Item: Item 8
Chunk 43
---
 capital requirements and other factors deemed relevant by our Board of Directors. A summary of our cash dividend activity for the nine months ended September 30, 2025 and 2024 is as follows: Declaration DateRecord DatePayment DateCashDividendper ShareTotalNine Months Ended September 30, 2025January 22, 2025March 10, 2025March 25, 2025$1.71$386 April 16, 2025June 10, 2025June 25, 2025$1.71$385 July 16, 2025September 10, 2025September 25, 2025$1.71$381 Nine Months Ended September 30, 2024January 23, 2024March 8, 2024March 22, 2024$1.63$379 April 16, 2024June 10, 2024June 25, 2024$1.63$378 July 16, 2024September 10, 2024September 25, 2024$1.63$378 On October 15, 2025, our Audit Committee declared a fourth quarter 2025 dividend to shareholders of $1.71 per share, payable on December 19, 2025 to shareholders of record at the close of business on December 5, 2025.Under our Board of Directors’ authorization, we maintain a common stock repurchase program. On October 15, 2024, our Audit Committee, pursuant to authorization granted by the Board of Directors, authorized an $8,000 increase to the common stock repurchase program. No duration has been placed on the common stock repurchase program, and we reserve the right to discontinue the program at any time. Repurchases may be made from time to time at prevailing market prices, subject to certain restrictions on volume, pricing and timing. The repurchases are effected from time to time in the open market, through negotiated transactions, including accelerated share repurchase agreements, and through plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Our stock repurchase program is discretionary, as we are under no obligation to repurchase shares. We repurchase shares under the program when we believe it is a prudent use of capital. The excess cost of the repurchased shares over par value is charged on a